Patent 11247965 was granted and assigned to Venatorx Pharmaceuticals Inc. on February, 2022 by the United States Patent and Trademark Office.
Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.